This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Analysts' Actions: ACN AMZN FB GS XOM

Stocks in this article: ACN AMZN FB GS XOM

Hewlett-Packard (HPQ) was downgraded at Goldman Sachs to sell from neutral. Earnings expectations should fall, Goldman said. $16 price target.

Linear Technology (LLTC) was downgraded to hold from buy, Stifel Nicolaus said. Checks show slower order growth, Stifel Nicolaus said.

Morgan Stanley (MS) was downgraded at Credit Suisse to neutral from outperform. Valuation call, Credit Suisse said.

Rackspace Hosting (RAX) was downgraded at Wells Fargo to market perform. Impacting the company is cloud computing, which is somewhat cannibalizing managed hosting growth, as are reduced bandwith prices, Wells Fargo said. Valuation range is now $47 to $52.

Charles Schwab (SCHW) was downgraded at Credit Suisse to neutral from outperform. Don't expect more earnings expansion in the capital markets space, Credit Suisse said.

Suntrust Banks (STI) was downgraded at Credit Suisse to neutral from outperform. Estimates were also cut, given a slower recovery, Credit Suisse said.

Texas Instruments (TXN) was downgraded at Stifel Nicolaus to hold from buy. Orders appears to have slowed down, Stifel Nicolaus said.

World Acceptance (WRLD) was downgraded at FBR Capital Markets to market perform from outperform. Valuation call, FBR Capital Markets said.

Exxon Mobil (XOM) was downgraded at Oppenheimer to perform from outperform. Company lacks near-term catalysts, Oppenheimer said.

Yahoo! (YHOO) was initiated with a buy rating at UBS. Potential monetization of its Asian Internet holdings drive the rating, the core business is viewed as having a fair value, UBS said. Price target is $27.


Apple (AAPL) was cut from the Conviction Buy List at Goldman Sachs. New products are not driving continued growth, Goldman said. $575 price target.

Actavis (ACT) estimates, target were boosted at Morgan Stanley. Shares are now seen reaching $101. Estimates were also increased, following the generic Pulmicort settlement, Morgan Stanley said. Overweight rating.

Amgen (AMGN) price target was raised at Oppenheimer. Shares are now seen reaching $100. Industry valuations are rising, Oppenheimer said. Perform rating.

Biogen (BIIB) price target and estimates were increased at Bernstein. Estimates were increased to account for a higher-than-expected price for recently approved Tecfidera, said Bernstein. Price target was increased to $201.

Sandisk (SNDK) estimates, price target were increased at Nomura. Estimates were raised through 2014. Company is seeing higher demand and is leveraged to a weaker yen, Nomura said. Buy rating and new $60 price target.

WisdomTree (WETF) price target and estimates were raised at Citigroup to reflect higher AUM and lower franchise risk. New price target is $13.50.

U.S. Steel (X) price target and estimates were cut at Bank of America/Merrill Lynch. Estimates were reduced to reflect a greater margin squeeze as iron ore prices fall and costs remain fixed, said Bank of America/Merrill Lynch. Price target was reduced to $14.

>To submit a news tip, email:


Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.
2 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs